Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Taiwan Advanced Nanotech's Enterprise Value is NT$40.3 Mil.
Taiwan Advanced Nanotech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-23.4 Mil. Therefore, Taiwan Advanced Nanotech's EV-to-FCF for today is -1.72.
The historical rank and industry rank for Taiwan Advanced Nanotech's EV-to-FCF or its related term are showing as below:
ROCO:6797'
s EV-to-FCF Range Over the Past 10 Years
Min: -138.08 Med: 1.01 Max: 12.63
Current: -2.36
During the past 9 years, the highest EV-to-FCF of Taiwan Advanced Nanotech was 12.63. The lowest was -138.08. And the median was 1.01.
ROCO:6797's EV-to-FCF is ranked worse than 100% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.445
vs ROCO:6797: -2.36
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Taiwan Advanced Nanotech's PE Ratio (TTM) for today is calculated as:
Taiwan Advanced Nanotech's share price for today is NT$13.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Taiwan Advanced Nanotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-7.410.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Taiwan Advanced Nanotech EV-to-FCF Related Terms
Taiwan Advanced Nanotech EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Taiwan Advanced Nanotech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiwan Advanced Nanotech EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Taiwan Advanced Nanotech's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Taiwan Advanced Nanotech's EV-to-FCF falls into.
Taiwan Advanced Nanotech's current Enterprise Value is NT$40.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Taiwan Advanced Nanotech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-23.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiwan Advanced Nanotech (ROCO:6797) has a EV-to-FCF of -1.72 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Taiwan Advanced Nanotech and its competitors. According to the industry distribution chart, Taiwan Advanced Nanotech ranks #999999 out of 414 companies in the Medical Devices & Instruments industry.
Is Taiwan Advanced Nanotech's EV-to-FCF too high?
Taiwan Advanced Nanotech's current EV-to-FCF is -1.72. Based on the distribution chart, Taiwan Advanced Nanotech ranks #999999 out of 414 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Taiwan Advanced Nanotech has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiwan Advanced Nanotech's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Taiwan Advanced Nanotech ranks #999999 out of 414 companies for EV-to-FCF. This places Taiwan Advanced Nanotech in the lower half of its industry. The industry median EV-to-FCF is 23.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.45, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Taiwan Advanced Nanotech and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiwan Advanced Nanotech's current EV-to-FCF is -1.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiwan Advanced Nanotech stock overvalued right now?
Based on GuruFocus' analysis, Taiwan Advanced Nanotech (ROCO:6797) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.40, compared to a current price of NT$13.20 — trading 1.5% below its estimated fair value. The current EV-to-FCF is -1.72. Taiwan Advanced Nanotech's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Taiwan Advanced Nanotech (ROCO:6797), the current EV-to-FCF is -1.72 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiwan Advanced Nanotech (ROCO:6797) Overvalued in 2026?
Based on GuruFocus' analysis, Taiwan Advanced Nanotech stock appears to be undervalued.
The current stock price of NT$13.20 is trading 1.5% below its estimated GF Value™ of NT$13.40.
GuruFocus considers Taiwan Advanced Nanotech to be Fairly Valued.
Key valuation signals for ROCO:6797:
EV-to-FCF: -1.72
GF Value™: NT$13.40 vs. price of NT$13.20 (1.5% below fair value)
No single metric tells the full story. See the ROCO:6797 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiwan Advanced Nanotech Inc is engaged in development and manufacturing of various functional nanoparticles and automated nucleic acid extraction machines and trading related businesses. With expertise in automation, buffer optimization and modification of magnetic beads, it focuses on offering customer convenient and practical solutions to advance research, life science and molecular diagnostics. It offers various products to meet the requirements of customers. The company's products include Automated Extraction Instruments; Reagent Kit; Mag Nanoparticles; and Consumables.
59GF Score
Get the complete analysis for ROCO:6797
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6797 has been successfully added to your 
